Can-Fite BioPharma Amended 13D Filing From Capital Point Shows 12.88% Stake, Includes Language Firm Initiated Added Legal Proceedings In Tel Aviv-Yafo District Court To Compel Co. To Convene Special General Meeting Of Shareholders